Corrigendum: TEOA inhibits proliferation and induces DNA damage of diffuse large B-cell lymphoma cells through activation of the ROS-dependent p38 MAPK signaling pathway.

Yu, Xingxing; Wang, Xin; Wang, Xu; Zhou, Yi; Li, Yanchun; Wang, Aiwei; Wang, Tongtong; An, Yihan; Sun, Weidong; Du, Jing; Tong, Xiangmin; Wang, Ying

Yu, Xingxing; Wang, Xin; Wang, Xu; Zhou, Yi; Li, Yanchun; Wang, Aiwei; Wang, Tongtong; An, Yihan; Sun, Weidong; Du, Jing; Tong, Xiangmin; Wang, Ying.

Afiliação

Yu X; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wang X; Department of Hematology, Fuyang Hospital of Anhui Medical University, Fuyang, China.
Wang X; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Zhou Y; School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.
Li Y; Department of Laboratory Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wang A; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wang T; Wangjiangshan Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
An Y; The Second Clinical Medical School of Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Sun W; Department of Hematology, The First People's Hospital of Fuyang, Hangzhou, China.
Du J; Wangjiangshan Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Tong X; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
Wang Y; Clinical Research Institute, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.